Extrathyroidal manifestations of Graves' disease: a 2014 update.
about
HyperthyroidismMorphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 CasesProspectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surfaceThe thyroid, the eyes and the gut: a possible connection.Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapySevere Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot StudyThe 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyComparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective TrialGenetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysisGraves'-like orbitopathy: do not forget IgG4-related disease.Clinical Endocrinology in the near future: a post-modern challenge.Role of genetic and non-genetic factors in the etiology of Graves' disease.Total thyroid ablation in Graves' orbitopathy.Endocrinology & Art. Virgin and child with Saint Anne by Albrecht Dürer (1471-1528).T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.Controversies in the management of Graves' disease in children.Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).Ophthalmic clues to the endocrine disorders.Radiotherapy for Graves' disease. The possible role of low-dose radiotherapyNatural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?Approach to Lower Extremity Edema.Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.Treatment of pretibial myxedema with intralesional immunomodulating therapy.A 2013 European survey of clinical practice patterns in the management of Graves' disease.Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.The 2017 Doyne Lecture: the orbit as a window to systemic disease.Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy.Preoperative management in patients with Graves' disease.Exophthalmos (Graves' orbitopathy) in an ancient sculpture.Elephantiasic Graves' Dermopathy in a Patient with Negative Thyroid-Receptor Auto-Antibodies.Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients.
P2860
Q27690661-51FB46EC-098F-4413-9DF0-DA4C9866CAB9Q28596143-E152D494-D070-4B30-90A7-2DE5FFA34900Q30883875-589D032E-E18F-4389-BECF-04B6DAB5A43CQ31047067-D0D33BA9-3894-4789-9A66-44D6C4715F95Q33574320-8AAD5850-8627-46D1-8643-79B4823F35D4Q33650208-B5C95D57-2FCB-493F-9A3C-40B2B7E3B757Q33802192-BD565EB7-D56E-40A7-A21D-F1545D957C45Q36243615-E2B5AD30-75B0-4B0C-87A7-60E22C61943DQ36437367-C2FC06B9-6F08-4381-821D-0486F30F8F99Q36738202-F06F05C3-9247-4CAA-A63E-BF26AC142E2EQ36811289-AD87A49C-D033-49C9-A3F7-AB6018358CF9Q37104833-C1DDEFEB-1A90-4F47-99CA-FB158B54D1E6Q37125294-3CBE83CC-DAD1-4247-88FB-74A12AD05D31Q38246519-1AC19323-4476-4CD2-99F2-98762870A307Q38255736-0BDA1023-0F40-44EC-BFB4-54D9B6535BCDQ38271025-9C32EC33-990F-4585-8F0B-1541816DBB38Q38367695-911648A8-7F77-43E3-9B93-2E1D98183909Q38410734-C9EB3231-4E26-473F-9E6C-5EDE519CE118Q38609536-A271F4F2-8572-4DD7-B4A3-6FB3B44A0046Q38692635-2C69F6B7-5F10-45FC-B7BE-025DDB2ADEB9Q38784922-A7BE3BA4-93C0-4226-8319-DE3F38663C56Q38827752-4D9C6213-E0CD-4045-9448-29A1D6197D8FQ38843328-5F9C9CB4-725B-4565-AD32-983B33EB6426Q38869637-8B9CEDB6-A14B-4EB3-B1EA-1773FD3484F2Q38939043-341AF89E-9FD7-42B8-B0AF-7655A801E013Q38948145-037A37D1-C2A6-419F-B5BB-A16005AF586DQ38963406-6824C549-5D69-480A-9AEF-27C3A4ACEF19Q38972962-489999CC-0CA0-4AA2-AF53-5C833507A504Q39177062-85F4A846-1689-4BC2-ACD3-15A632FBC8FBQ39552770-42D673EF-FE78-424A-AED6-86E8D346BCDAQ40962257-23B1A146-4EC9-4532-BBD4-3DB662407955Q41080944-C66A2E19-98BF-4960-A65D-7B4AE5D9CA30Q41592139-1A909A0B-A060-4FF8-AE94-EB1332214941Q41828250-CC7279FF-F7AC-4D84-A445-10DCD13950FEQ44059279-E457FFC1-5A75-47FE-A3EC-DD31D10CA10AQ46870418-EA0D60E8-CDB0-4FD2-BC7F-D2D2C7029883Q47122099-84452801-2099-44B6-88F9-6E3A92663114Q47316949-8569A9C5-8095-42E0-A6A2-19BC4AF3B046Q49164059-9930A405-742B-4C25-9D60-E677ECAAEC00Q50254727-829AE83E-7547-4B0A-A844-C101594C7EEC
P2860
Extrathyroidal manifestations of Graves' disease: a 2014 update.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Extrathyroidal manifestations of Graves' disease: a 2014 update.
@en
type
label
Extrathyroidal manifestations of Graves' disease: a 2014 update.
@en
prefLabel
Extrathyroidal manifestations of Graves' disease: a 2014 update.
@en
P2860
P1476
Extrathyroidal manifestations of Graves' disease: a 2014 update.
@en
P2093
Luigi Bartalena
Vahab Fatourechi
P2860
P2888
P304
P356
10.1007/S40618-014-0097-2
P577
2014-06-10T00:00:00Z
P6179
1016789120